BR112023026523A2 - Métodos para fabricar aav - Google Patents
Métodos para fabricar aavInfo
- Publication number
- BR112023026523A2 BR112023026523A2 BR112023026523A BR112023026523A BR112023026523A2 BR 112023026523 A2 BR112023026523 A2 BR 112023026523A2 BR 112023026523 A BR112023026523 A BR 112023026523A BR 112023026523 A BR112023026523 A BR 112023026523A BR 112023026523 A2 BR112023026523 A2 BR 112023026523A2
- Authority
- BR
- Brazil
- Prior art keywords
- cells
- polynucleotide sequence
- aav
- methods
- culture medium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163211877P | 2021-06-17 | 2021-06-17 | |
| PCT/IB2022/000347 WO2022263930A2 (en) | 2021-06-17 | 2022-06-17 | Aav manufacturing methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023026523A2 true BR112023026523A2 (pt) | 2024-03-05 |
Family
ID=82850181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023026523A BR112023026523A2 (pt) | 2021-06-17 | 2022-06-17 | Métodos para fabricar aav |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240279682A1 (https=) |
| EP (1) | EP4355887A2 (https=) |
| JP (1) | JP2024523891A (https=) |
| KR (1) | KR20240054958A (https=) |
| CN (1) | CN117730154A (https=) |
| AU (1) | AU2022292164A1 (https=) |
| BR (1) | BR112023026523A2 (https=) |
| CA (1) | CA3222723A1 (https=) |
| IL (1) | IL309351A (https=) |
| MX (1) | MX2023015291A (https=) |
| WO (1) | WO2022263930A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4713466A1 (en) * | 2023-05-18 | 2026-03-25 | Solid Biosciences Inc. | Single plasmid system for aav production |
| WO2025063664A1 (ko) * | 2023-09-18 | 2025-03-27 | 삼성바이오에피스 주식회사 | 재조합 aav 생산을 위한 단일 벡터 시스템 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017112948A1 (en) * | 2015-12-24 | 2017-06-29 | University Of Florida Research Foundation, Inc. | Improved aav production using suspension adapted cells |
| MA44546B1 (fr) | 2016-06-15 | 2021-03-31 | Univ California | Virus adéno-associés variants et procédés d'utilisation |
| KR20210093862A (ko) * | 2018-09-21 | 2021-07-28 | 나이트스타엑스 리미티드 | 유전자 요법 벡터를 제작하기 위한 조성물 및 방법 |
| CN109666697B (zh) * | 2019-01-30 | 2020-03-10 | 广州派真生物技术有限公司 | 一种提高腺相关病毒产量的生产工艺 |
| JP2023503850A (ja) * | 2019-11-14 | 2023-02-01 | バイオマリン ファーマシューティカル インコーポレイテッド | 肝臓特異的遺伝子療法ベクターによる遺伝性血管浮腫の治療 |
-
2022
- 2022-06-17 KR KR1020247000732A patent/KR20240054958A/ko active Pending
- 2022-06-17 US US18/571,478 patent/US20240279682A1/en active Pending
- 2022-06-17 MX MX2023015291A patent/MX2023015291A/es unknown
- 2022-06-17 WO PCT/IB2022/000347 patent/WO2022263930A2/en not_active Ceased
- 2022-06-17 IL IL309351A patent/IL309351A/en unknown
- 2022-06-17 AU AU2022292164A patent/AU2022292164A1/en active Pending
- 2022-06-17 BR BR112023026523A patent/BR112023026523A2/pt not_active Application Discontinuation
- 2022-06-17 EP EP22753761.0A patent/EP4355887A2/en active Pending
- 2022-06-17 CA CA3222723A patent/CA3222723A1/en active Pending
- 2022-06-17 CN CN202280050835.0A patent/CN117730154A/zh active Pending
- 2022-06-17 JP JP2023577659A patent/JP2024523891A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN117730154A (zh) | 2024-03-19 |
| CA3222723A1 (en) | 2022-12-22 |
| KR20240054958A (ko) | 2024-04-26 |
| JP2024523891A (ja) | 2024-07-02 |
| AU2022292164A1 (en) | 2024-02-01 |
| WO2022263930A3 (en) | 2023-01-26 |
| MX2023015291A (es) | 2024-03-25 |
| WO2022263930A2 (en) | 2022-12-22 |
| EP4355887A2 (en) | 2024-04-24 |
| IL309351A (en) | 2024-02-01 |
| US20240279682A1 (en) | 2024-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023026523A2 (pt) | Métodos para fabricar aav | |
| MX391337B (es) | Sistemas de replicón de arterivirus recombinantes y usos de estos. | |
| BR112016020783A2 (pt) | Vetores de aav adicionalmente melhorados produzidos em células de inseto | |
| BR112018002214A2 (pt) | ?métodos para cultivar células e para produzir uma proteína, meios de cultura de células cho e de batelada alimentada e/ou alimentação, e, alimentação de cultura de células cho? | |
| CO2020002674A2 (es) | Moléculas de ácido nucleico y sus usos | |
| Jaakkola et al. | Closely related archaeal Haloarcula hispanica icosahedral viruses HHIV-2 and SH1 have nonhomologous genes encoding host recognition functions | |
| BR112013005139A2 (pt) | produção estável de vetores lentivirais | |
| BR112015028666B8 (pt) | Composição detergente, método para produzir a mesma, método para a limpeza de um objeto e usos da composição | |
| EA202190512A1 (ru) | Композиции и способы для производства векторов для генной терапии | |
| HRP20180146T1 (hr) | Vektori i sljedovi namijenjeni liječenju bolesti | |
| RU2010108308A (ru) | Способ получения гетерогенных белков | |
| AR074961A1 (es) | Genes asociados con el numero de retonos de plantas y sus usos. | |
| BR112015022189A2 (pt) | microvesícula, método para produção e uso da mesma | |
| BR112021026326A2 (pt) | Sacarose fosforilase engenheirada, composição, sequência de polinucleotídeo, vetor de expressão, célula hospedeira, e, método para produzir uma sacarose fosforilase engenheirada | |
| SA518391787B1 (ar) | تركيبة لعلاج متلازمة كريغلر نجار | |
| BR112016015678A2 (pt) | Polipeptídeo contendo fragmentos mutantes de ospa, ácido nucleico, vetor, célula hospedeira, processo para sua produção, composição farmacêutica, e seu uso | |
| BR112022003563A2 (pt) | Composições e métodos para modificar uma característica da planta sem modificar o seu genoma | |
| BR112019023881A2 (pt) | otimização da expressão de serino proteases em células hospedeiras | |
| CR20200507A (es) | Composiciones aav, métodos de fabricación y métodos de uso | |
| BR112022014738A2 (pt) | Vetores à base de poxvírus produzidos por dna natural ou sintético e usos dos mesmos | |
| BR112014019166A2 (pt) | promotores para expressão aumentada de proteína em meningococos | |
| MX2024002641A (es) | Uso de micro ácido ribonucleico (arn) para la regulación por disminución de la expresión de transgenes citotóxicos mediante el virus vaccinia ankara modificado (mva). | |
| BR112021024819A2 (pt) | Acetato quinase engenheirada, composição, sequência de polinucleotídeos, vetor de expressão, célula hospedeira, e, método de produção de uma acetato quinase engenheirada | |
| PY1935029A (es) | Molécula de ácido nucleico cry1da codón-optimizada, constructo de ácido nucleico, vector, célula huésped, célula vegetal, planta transgénica, método para transformar una célula, método para producir una planta transgénica, método de control de plagas invertebradas de plantas de cultivo y usos de la molécula de ácido nucleico | |
| MX360759B (es) | Polipeptidos con actividades lipasa y polinucleotidos que los codifican. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing |